Novozymes A/S (OTCMKTS:NVZMY) Upgraded at Kepler Capital Markets

Novozymes A/S (OTCMKTS:NVZMY) was upgraded by equities researchers at Kepler Capital Markets from a “hold” rating to a “strong-buy” rating in a research note issued to investors on Wednesday,Zacks.com reports.

Several other brokerages have also recently commented on NVZMY. Rothschild & Co Redburn raised Novozymes A/S to a “strong-buy” rating in a research report on Friday, March 27th. Zacks Research cut Novozymes A/S from a “hold” rating to a “strong sell” rating in a research report on Monday, May 4th. Two equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Buy”.

Novozymes A/S Stock Down 0.3%

Shares of NVZMY stock opened at $59.29 on Wednesday. The stock has a market cap of $24.58 billion, a P/E ratio of 40.06, a price-to-earnings-growth ratio of 1.11 and a beta of 0.98. Novozymes A/S has a one year low of $49.90 and a one year high of $75.99. The stock has a fifty day moving average price of $58.35 and a 200 day moving average price of $60.98. The company has a debt-to-equity ratio of 0.12, a current ratio of 0.72 and a quick ratio of 0.44.

Novozymes A/S (OTCMKTS:NVZMY) last issued its earnings results on Tuesday, May 5th. The biotechnology company reported $0.51 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.31). The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.32 billion. Novozymes A/S had a return on equity of 6.57% and a net margin of 14.22%. Analysts predict that Novozymes A/S will post 2.43 earnings per share for the current year.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).